449 related articles for article (PubMed ID: 29752278)
41. Renal hybrid oncocytic/chromophobe tumor associated with multiple schwannomas: Case report and literature review.
Liu G; Li Y; Li Z; Zhou J; Huo Z; Ji Z
Medicine (Baltimore); 2017 Dec; 96(48):e8939. PubMed ID: 29310387
[TBL] [Abstract][Full Text] [Related]
42. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.
Zheng G; Chaux A; Sharma R; Netto G; Caturegli P
Exp Mol Pathol; 2013 Feb; 94(1):29-32. PubMed ID: 22705098
[TBL] [Abstract][Full Text] [Related]
43. Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma.
Xiao Y; Clima R; Busch J; Rabien A; Kilic E; Villegas SL; Timmermann B; Attimonelli M; Jung K; Meierhofer D
Cancer Res; 2020 Sep; 80(18):3830-3840. PubMed ID: 32694149
[TBL] [Abstract][Full Text] [Related]
44. Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma.
Flack CK; Calaway AC; Miller BL; Picken MM; Gondim DD; Idrees MT; Abel EJ; Gupta GN; Boris RS
Urol Oncol; 2019 Nov; 37(11):811.e17-811.e21. PubMed ID: 31451335
[TBL] [Abstract][Full Text] [Related]
45. [Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features].
Zhang W; Yu WJ; Chen YQ; Kang EH; Liu Y; Zhuang J; Jiang YX; Chu J; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):692-697. PubMed ID: 27760610
[No Abstract] [Full Text] [Related]
46. Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy.
Ginzburg S; Uzzo R; Al-Saleem T; Dulaimi E; Walton J; Corcoran A; Plimack E; Mehrazin R; Tomaszewski J; Viterbo R; Chen DY; Greenberg R; Smaldone M; Kutikov A
J Urol; 2014 Feb; 191(2):296-300. PubMed ID: 23899990
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
Liu L; Qian J; Singh H; Meiers I; Zhou X; Bostwick DG
Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191
[TBL] [Abstract][Full Text] [Related]
48. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
49. Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.
Dvorakova M; Dhir R; Bastacky SI; Cieply KM; Acquafondata MB; Sherer CR; Mercuri TL; Parwani AV
Diagn Pathol; 2010 May; 5():32. PubMed ID: 20497539
[TBL] [Abstract][Full Text] [Related]
50. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
51. Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic and molecular-genetic analysis of 10 cases.
Rogala J; Kojima F; Alaghehbandan R; Ptakova N; Bravc A; Bulimbasic S; Perez Montiel D; Slisarenko M; Ali L; Kuthi L; Pivovarcikova K; Michalova K; Bartovic B; Bartos Vesela A; Dolejsova O; Michal M; Hes O
Bosn J Basic Med Sci; 2022 Jul; 22(4):531-539. PubMed ID: 35276058
[TBL] [Abstract][Full Text] [Related]
52. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
Okoń K; Sińczak-Kuta A
Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
[TBL] [Abstract][Full Text] [Related]
53. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study.
Li X; Ma Q; Nie P; Zheng Y; Dong C; Xu W
Br J Radiol; 2022 Jan; 95(1129):20210534. PubMed ID: 34735296
[TBL] [Abstract][Full Text] [Related]
54. Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case.
Pires-Luis A; Montezuma D; Vieira J; Ramalho-Carvalho J; Santos C; Teixeira M; Jerónimo C; Henrique R
Exp Mol Pathol; 2018 Dec; 105(3):352-356. PubMed ID: 30343009
[TBL] [Abstract][Full Text] [Related]
55. FOXI1 Immunohistochemistry Differentiates Benign Renal Oncocytoma from Malignant Chromophobe Renal Cell Carcinoma.
Molnar A; Horvath CA; Czovek P; Szanto A; Kovacs G
Anticancer Res; 2019 Jun; 39(6):2785-2790. PubMed ID: 31177114
[TBL] [Abstract][Full Text] [Related]
56. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
[TBL] [Abstract][Full Text] [Related]
57. Giant renal oncocytoma: differential diagnosis.
Wang YT; Liu KL; Chueh SC; Tsang YM
J Formos Med Assoc; 2003 Jan; 102(1):46-8. PubMed ID: 12684612
[TBL] [Abstract][Full Text] [Related]
58. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
59. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis.
Patel HD; Druskin SC; Rowe SP; Pierorazio PM; Gorin MA; Allaf ME
BJU Int; 2017 May; 119(5):661-666. PubMed ID: 28058773
[TBL] [Abstract][Full Text] [Related]
60. Low-Grade Oncocytic Tumor: Report of Two Cases of An Emerging Entity in the Spectrum of Oncocytic Renal Neoplasms.
Sharma D; Pai T; Prakash G; Desai S; Menon S
Turk Patoloji Derg; 2022; 38(2):162-166. PubMed ID: 34514579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
